International Patent: ANTIBODY SPECIFICALLY BINDING TO CLAUDIN18.2 AND PREPARATION METHOD THEREFOR AND USE THEREOF

GENEVA, July 2 -- GRACELL BIOTECHNOLOGIES (SHANGHAI) CO., LTD. filed a patent application (CN2024/081935) for “ANTIBODY SPECIFICALLY BINDING TO CLAUDIN18.2 AND PREPARATION METHOD THEREFOR AND USE THEREOF”. With publication no. WO/2024/188341, here are the other details related to the patent application:

Kind: Corrected version of pamphlet [A9]

IPC: C07K 16/28

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....